Citations

Citations to this article as recorded by  

• Salidroside attenuates myocardial fibrosis through hindering oxidative stress and inflammation via SIRT1/EZH2 signaling pathway
  Wenxue Jin, Xiulan Qiao
  Molecular & Cellular Toxicology.2026;[Epub]     CrossRef
• Sympathetic-like-integrated engineered heart tissue models AGEs-induced adverse remodeling
  Yu-hong Wang, Xi-ming Zhu, Xiang Long, Shuo-ji Zhu, Ting-ting Liu, Moussa Ide Nasser, Zi-ming Liao, Jia-cheng Shi, Shu-ting Zhang, Jia-lin Liao, David T. W. Lui, Ping Zhu, Bin Yao, Hai-xia Guan
  Cardiovascular Diabetology.2026;[Epub]     CrossRef
• Epigenetic Regulation and Molecular Mechanisms in Cardiovascular Diseases: A Review of Recent Advances and Therapeutic Implications
  Ewelina Młynarska, Kinga Bojdo, Anna Bulicz, Katarzyna Hossa, Wiktoria Lisińska, Paulina Stasiak, Jacek Rysz, Beata Franczyk
  International Journal of Molecular Sciences.2026; 27(2): 983.     CrossRef
• Aerobic Exercise Stabilizes HIF1α through P4HA1 to Activate Nrf2/GPX4 Inhibiting Ferroptosis and Attenuating Diabetic Cardiomyopathy
  Sicong Xie, Mingjun Wang, Chenshuo Yu, Fei Zhou, Yu Zheng, Ning Zhang, Yushan Chen, Weihan Kong, Wenzhe Si, Jiaxuan Xu, Yang Zhang, Lei Wang
  Diabetes & Metabolism Journal.2026;[Epub]     CrossRef
• Cannabidiol and diabetic heart disease: Mechanistic evidence and translational challenges
  Afolake Arowolo, Oluyomi Adeyemi, Toluwalope Ajonijebu, Aminu Musa, Hygon Mutavhatsindi, Rabia Johnson, Kenechukwu Obikeze
  Biomedicine & Pharmacotherapy.2026; 198: 119354.     CrossRef
• A Computational Approach to Identify Novel Protein Targets Uncovers New Potential Mechanisms of Action of Mirtazapine S(+) and R(−) Enantiomers in Rett Syndrome
  Ottavia Maria Roggero, Nicolò Gualandi, Viviana Ciraci, Vittoria Berutto, Emanuele Carosati, Enrico Tongiorgi
  Journal of Neurochemistry.2025;[Epub]     CrossRef
• ER-α36 prevents high glucose-induced cellular senescence and apoptosis in renal tubular cell
  Dehai Yu, Ling Luo, Yu Liang, Huili Zhou, Yinghui Xiao, Xingna An, Yingzhao Wang, Zhonggao Xu, Weixia Sun, Wanning Wang
  Frontiers in Endocrinology.2025;[Epub]     CrossRef
• EZH2 in non-cancerous diseases: expanding horizons
  Renjing Jin, Jianlin Zhang, Yuqing Wang, Ziyu Chen, Xuan He, Xintong Zhang, Zhen Tan, Celina G Kleer, Ye Li, Deli Wang, Lixiang Xue
  Protein & Cell.2025;[Epub]     CrossRef
• Nuclear receptors in metabolism and diseases: Mechanistic and therapeutic insights
  Chen-Ying Zhu, Pei-Han Yu, Qi Sun, De-Fei Hong, Chang Yang, Hua Naranmandura
  Pharmacological Research.2025; 218: 107862.     CrossRef
• Epigenetics Plays a Role in the Pathogenesis and Treatment of Diabetes
  Kajetan Kiełbowski, Estera Bakinowska, Andrzej Pawlik
  Genes.2025; 16(7): 769.     CrossRef
• UM-164 alleviates high starch diet-induced hepatic abnormal lipid accumulation via inhibiting pentose phosphate pathway and mTOR-SREBPs signaling in channel catfish (Ictalurus punctatus)
  Qisheng Lu, Xiaochen Ma, Guoli Han, Jinglu Jia, Jingyue Cao, Haokun Liu, Junyan Jin, Zhimin Zhang, Yunxia Yang, Xiaoming Zhu, Shouqi Xie, Dong Han
  Aquaculture Reports.2025; 44: 103031.     CrossRef
• Β-Hydroxybutyrate inhibits centriole duplication and mitochondrial dysfunction through β-hydroxybutyrylation of ANXA11 in diabetic cardiomyopathy rats
  Jingyu Liu, Bin Wu, Xin Nian, Shiying Huang, Yaxian Song, Yaxin Guan, Fang Sun, Xiao Meng, Shengting Huang
  Cellular Signalling.2025; 136: 112086.     CrossRef
• The role of AMPK signaling pathway in the pathogenesis of type 2 diabetes mellitus with its complications and related metabolic disorders
  Kibur Hunie Tesfa, Chernet Desalegn Gebeyehu, Asrat Tadele Ewunetie, Endalkachew Gugsa, Amare Nigatu Zewdie, Gashaw Dessie, Hiwot Tezera Endale
  Metabolism Open.2025; 28: 100397.     CrossRef
• Metabolic-epigenetic interactions in heart failure: Current understanding and future directions
  Benjamin Flowers, Bea Duric
  Biochemical and Biophysical Research Communications.2025; 783: 152608.     CrossRef
• Cardiometabolic Therapies Shape Non-Coding RNA Landscapes in Cardiovascular Fibrosis
  Erica Floris, Francesco Nutile, Claudia Cozzolino, Virginia Pontecorvi, Antonella Bordin, Elena De Falco, Vittorio Picchio, Isotta Chimenti, Francesca Pagano
  Metabolites.2025; 15(10): 664.     CrossRef
• Emerging in Diabetic Cardiomyopathy: Molecular Pathways and Targets for Therapeutic Intervention
  Mansi Vinodkumar Trivedi, Hemant R. Jadhav, Anil Bhanudas Gaikwad
  Drug Development Research.2025;[Epub]     CrossRef
• An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory
  Tongyue Yang, Feng Qi, Feng Guo, Mingwei Shao, Yi Song, Gaofei Ren, Zhao Linlin, Guijun Qin, Yanyan Zhao
  Molecular Medicine.2024;[Epub]     CrossRef
• Farrerol Alleviates Diabetic Cardiomyopathy by Regulating AMPK-Mediated Cardiac Lipid Metabolic Pathways in Type 2 Diabetic Rats
  Jia Tu, Qiaoling Liu, Huirong Sun, Luzhen Gan
  Cell Biochemistry and Biophysics.2024; 82(3): 2427.     CrossRef
• Diabetes Promotes Myocardial Fibrosis via AMPK/EZH2/PPAR-γ Signaling Pathway (Diabetes Metab J 2024;48:716-29)
  Shan-Shan Li, Lu Pan, Shipeng Dang, Ru-Xing Wang
  Diabetes & Metabolism Journal.2024; 48(6): 1181.     CrossRef
• Targeting Cardiac Fibrosis in Diabetic Heart Failure: The Role of the EZH2, AMPK, and PPAR-γ Pathways (Diabetes Metab J 2024;48:716-29)
  Jooyeop Lee, Joon Ho Moon
  Diabetes & Metabolism Journal.2024; 48(6): 1176.     CrossRef

Citations

Citations to this article as recorded by  

• Clinical Determinants and Prognostic Significance of Circulating Angiopoietin-Like Protein 3 Levels in Patients With Chronic Coronary Syndrome
  Hiroki Tanaka, Yunosuke Matsuura, Kinuko Yamamoto, Soichi Komaki, Masashi Yamaguchi, Kohei Moribayashi, Takeshi Ideguchi, Michikazu Nakai, Toshihiro Tsuruda, Koichi Kaikita
  Circulation Reports.2026; 8(3): 453.     CrossRef
• CURRENT ADVANCES IN LIPOPROTEIN(A) MANAGEMENT: CLINICAL SIGNIFICANCE AND EMERGING THERAPIES
  Szymon Zysiak, Rafał Bednarczyk, Natalia Bednarczyk, Agnieszka Kurek, Natalia Krajewska, Aleksandra Lejman, Aleksandra Mazurkiewicz, Hubert Sidor, Monika Wołosik, Radosław Krzysztof Binkowski
  International Journal of Innovative Technologies in Social Science.2026;[Epub]     CrossRef
• Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk in Populations With Different Low‐Density Lipoprotein Cholesterol Elevations: A Prospective Cohort Study
  Hong Zheng, Guanlin Chen, Zhenyu Huo, Yulong Lan, Yuxian Wang, Peng Fu, Weiqiang Wu, Haixiang Zheng, Kuangyi Wu, Zegui Huang, Dan Wu, Shouling Wu, Youren Chen
  Journal of the American Heart Association.2026;[Epub]     CrossRef
• The mechanism of perilla oil in regulating lipid metabolism
  Jiawei Xia, Yi Wang, Xin Li, Li Liu, Pin Zhang, Wendong Dai, Peng Luo, Guoze Wang, Yanhong Li
  Food Chemistry.2025; 476: 143318.     CrossRef
• The effect of vitamin E supplementation on serum low-density lipoprotein oxidization: A systematic review and meta-analysis of clinical trials
  Sepide Amini, Fatemeh Navab, Mohammad Hossein Rouhani, Tannaz Jamialahmadi, Mohammad Bagherniya, Prashant Kesharwani, Amirhossein Sahebkar
  European Journal of Pharmacology.2025; 997: 177491.     CrossRef
• Acromegaly and the risk of cancer: a nationwide population-based cohort study in Korea
  Yeo Song Kim, Jae-Seung Yun, Hyunho Kim, Sin Soo Jeun, Bongseong Kim, Sea-Won Lee, Jung Eun Lee, Kyuho Kim, Seung-Hyun Ko, Yu-Bae Ahn, Kyungdo Han, Seung Ho Yang
  European Journal of Endocrinology.2025; 192(3): 220.     CrossRef
• Cholesterol-modifying strategies for Alzheimer disease: promise or fallacy?
  Katia Azarfar, Boris Decourt, Brandon Sanchez Camacho, John Joshua Lawrence, Tania R. Omondi, Marwan N. Sabbagh
  Expert Review of Neurotherapeutics.2025; 25(5): 521.     CrossRef
• Recent Advances in the Management of Dyslipidemia: A Systematic Review
  Huang Jacky Xiao Feng, Yousaf Adil, Moon Julie, Ahmed Ramiz, Uppal Krishma, Sudhakar Pemminati
  Cureus.2025;[Epub]     CrossRef
• Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins
  Gala Araujo, Leidy Marian Valencia, Agata Martin-Ozimek, Yosdel Soto, Spencer D. Proctor
  Frontiers in Immunology.2025;[Epub]     CrossRef
• Statins and adhesion molecules: a review of a novel pleiotropic property of statins
  Mahvash Sadeghi, Sajad Dehnavi, Sanaz Keshavarz Shahbaz, Khadijeh Koushki, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar
  Immunologic Research.2025;[Epub]     CrossRef
• Discordance of Small Dense LDL Cholesterol Beyond LDL Cholesterol or Non–HDL Cholesterol and Carotid Plaque
  Jinqi Wang, Xiaoyu Zhao, Yanchen Zhao, Rui Jin, Yunfei Li, Jiahe Wang, Yueruijing Liu, Zhiyuan Wu, Xiuhua Guo, Lixin Tao
  JACC: Asia.2025; 5(8): 1012.     CrossRef
• Hyperlipidemia and atherosclerosis: experimental models
  K. I. Davletova, E. L. Chernolovskaya
  Bulletin of Siberian Medicine.2025; 24(2): 141.     CrossRef
• CORRECTION OF DYSLIPIDEMIA: HISTORICAL ASPECT AND CURRENT VIEW OF THE PROBLEM (REVIEW, PART IІ)
  Dmytro D. Diachuk, Galina Z. Moroz, Oleksandr M. Tkalenko
  Clinical and Preventive Medicine.2025; (4): 134.     CrossRef
• Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial
  Daniel Gaudet, Malgorzata Gonciarz, Xi Shen, Jennifer K. Leohr, Thomas P. Beyer, Jonathan W. Day, Garrett R. Mullins, Eugene Y. Zhen, Maryalice Hartley, Miriam Larouche, Robert J. Konrad, Olivier Benichou, Giacomo Ruotolo
  Nature Medicine.2025; 31(8): 2632.     CrossRef
• Post-transcriptional targeting of PCSK9 by microRNAs: From mechanisms to therapeutic potential
  Maryam Mahjoubin-Tehran, Samaneh Rezaei, Tannaz Jamialahmadi, Prashant Kesharwani, Amirhossein Sahebkar
  Human Gene.2025; 45: 201456.     CrossRef
• Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia
  Edomias Adyamseged Berhe, Rediet Ambachew Sema, Yididya Mehari Tesfaye, Abel Andargie Berhane, Mikale Dawit, Ephrem Mamo Gebrehiwot, Subah Abderehim Yesuf, Balamurugan Ramatchandirin
  Journal of Diabetes Research.2025;[Epub]     CrossRef
• Dendrobium huoshanense C. Z. Tang & S. J. Cheng alleviates atherosclerosis by reducing lipid and improving vascular endothelial dysfunction
  Xiang-Cheng Fan, Wei-You Cao, Min-Yang He, Hui-Kai Wang, Qing Hao, Wen-Jing Liu, Zhao-Ying Ren, Li-Jun Wang, Jing-Yu Wang, Fei-Xue Wang, Lin Jiang, Qiu-Sheng Zheng, Jun Ma, Feng Zhang, Ji-Chun Han, Lei Zheng
  Frontiers in Nutrition.2025;[Epub]     CrossRef
• Two Sides of Triglycerides in Atherogenesis: An Essential Contributor
  Anastasia V Poznyak, Sergey Kozlov, Gulalek A Babayeva, Vasily N Sukhorukov, Alexander N Orekhov
  Clinical Medicine Insights: Cardiology.2025;[Epub]     CrossRef
• Time-Restricted Eating, ANGPTL4, and Reduction in Residual Cardiovascular Risk
  Alejandro Gugliucci
  Journal of Clinical Medicine.2025; 14(19): 7026.     CrossRef
• Genetic insights into lipid traits and atherosclerosis risk: a Mendelian randomization and polygenic risk score analysis
  Hongliang Zhang, Xiaoyu Long, Guannan Niu, Wence Shi, Zhenyan Zhao, Dejing Feng, Hui Sun, Yongjian Wu
  International Journal of Surgery.2025; 111(10): 6802.     CrossRef
• Statins as Modulators of Epithelial to Mesenchymal Transition in Cardiovascular-Kidney-Metabolic Syndrome: a Comprehensive Review of Mechanisms and Therapeutic Implications
  Fatemeh Askarizadeh, Wael Almahmeed, Kasim Sakran Abass, Salim Virani, Amirhossein Sahebkar
  Current Atherosclerosis Reports.2025;[Epub]     CrossRef
• Gut microbiota–cholesterol crosstalk in cardiovascular diseases: mechanisms, metabolites, and therapeutic modulation
  Mohammad Abavisani, Seyed Mohammad Sajjadi, Negar Ebadpour, Sercan Karav, Amirhossein Sahebkar
  Nutrition & Metabolism.2025;[Epub]     CrossRef
• Innovations in Diagnosis and Treatment of Coronary Artery Disease
  Salaheldin Agamy, Sheref Zaghloul, Zahid Khan, Ahmed Shahin, Ramy Kishk, Ahmed Smman, Luciano Candilio
  Diagnostics.2025; 16(1): 98.     CrossRef
• The role of adherence in patients with chronic diseases
  Michel Burnier
  European Journal of Internal Medicine.2024; 119: 1.     CrossRef
• Bempedoic acid: new evidence and recommendations on use
  Kristina Paponja, Ivan Pećin, Željko Reiner, Maciej Banach
  Current Opinion in Lipidology.2024; 35(1): 41.     CrossRef
• Genetic insights into repurposing statins for hyperthyroidism prevention: a drug-target Mendelian randomization study
  Anqi Huang, Xinyi Wu, Jiaqi Lin, Chiju Wei, Wencan Xu
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Targeting host-specific metabolic pathways—opportunities and challenges for anti-infective therapy
  Monika I. Konaklieva, Balbina J. Plotkin
  Frontiers in Molecular Biosciences.2024;[Epub]     CrossRef
• Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect?
  Petros Adamidis, Despoina Pantazi, Iraklis Moschonas, Evangelos Liberopoulos, Alexandros Tselepis
  Journal of Cardiovascular Development and Disease.2024; 11(3): 72.     CrossRef
• Modulating effects of crocin on lipids and lipoproteins: Mechanisms and potential benefits
  Habib Yaribeygi, Mina Maleki, Farin Rashid-Farrokhi, Payman Raise Abdullahi, Mohammad Amin Hemmati, Tannaz Jamialahmadi, Amirhossein Sahebkar
  Heliyon.2024; 10(7): e28837.     CrossRef
• Assessing the Benefits of Lifestyle Influences on Cardiovascu-lar Health After Acute Coronary Syndrome
  Marius Rus, Claudia Elena Stanis, Paula Marian, Lilliana Oana Pobirci, Loredana Ioana Banszki, Veronica Huplea, Gheorghe Adrian Osiceanu, Bianca-Maria Pop, Gabriela Dogaru, Felicia Liana Andronie-Cioara
  Balneo and PRM Research Journal.2024; 15(Vol.15, no): 660.     CrossRef
• ​Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction
  Ziyi Sun, Zhangjun Yun, Jianguo Lin, Xiaoning Sun, Qingqing Wang, Jinlong Duan, Cheng Li, Xiaoxiao Zhang, Siyu Xu, Zeqi Wang, Xingjiang Xiong, Kuiwu Yao
  Journal of Translational Medicine.2024;[Epub]     CrossRef
• Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies
  Zaheer Qureshi, Mikail Khanzada, Adnan Safi, Eeshal Fatima, Faryal Altaf, Timothy J. Vittorio
  Annals of Medicine & Surgery.2024; 86(5): 2818.     CrossRef
• Therapeutic approach in the treatment of dyslipidemia: Novelties and challenges
  Katarina Lalić, Nataša Rajković, Ljiljana Popović, Sandra Singh-Lukač, Iva Rasulić, Ana Petakov, Milica Krstić, Marija Mitrović
  Galenika Medical Journal.2024; 3(9): 31.     CrossRef
• Lipid Variability Induces Endothelial Dysfunction by Increasing Inflammation and Oxidative Stress
  Marie Rhee, Joonyub Lee, Eun Young Lee, Kun-Ho Yoon, Seung-Hwan Lee
  Endocrinology and Metabolism.2024; 39(3): 511.     CrossRef
• Exploring the Perceptions and Behaviours of UK Prescribers Concerning Novel Lipid-Lowering Agent Prescriptions: A Qualitative Study
  Sarah Baig, Shahrauz Mughal, Yousuf Murad, Mandeep Virdee, Zahraa Jalal
  Pharmacy.2024; 12(4): 104.     CrossRef
• Need of education and training of healthcare professionals on the PCSK9 inhibitors in cardiovascular disease
  Jan Schjøtt, Kristine Heitmann
  European Journal of Cardiovascular Nursing.2024; 23(8): e191.     CrossRef
• CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis
  Xize Wu, Changbin Yuan, Jiaxiang Pan, Yi Zhou, Xue Pan, Jian Kang, Lihong Ren, Lihong Gong, Yue Li
  Scientific Reports.2024;[Epub]     CrossRef
• Lessons from PROMINENT and prospects for pemafibrate
  Jean-Charles Fruchart, Jamila Fruchart-Najib, Shizuya Yamashita, Peter Libby, Koutaro Yokote, Tatsuhiko Kodama, Yohei Tomita, Paul M. Ridker, Michel P. Hermans, Alberto Zambon
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• A novel lncRNA GM47544 modulates triglyceride metabolism by inducing ubiquitination-dependent protein degradation of APOC3
  Qianqian Xiao, Luyun Wang, Jing Wang, Man Wang, Dao Wen Wang, Hu Ding
  Molecular Metabolism.2024; 88: 102011.     CrossRef
• Advances in pharmacotherapy of dyslipidemia
  Harshitha Chinta
  National Journal of Pharmacology and Therapeutics.2024; 2(2): 68.     CrossRef
• ANGPTL3 as a target for treating lipid disorders in type 2 diabetes patients
  Jingfei Chen, Qin Luo, Yanfeng Yi, Jiangang Wang, Pengfei Chen, Fei Luo, Zhenfei Fang
  Lipids in Health and Disease.2024;[Epub]     CrossRef
• Assessing the effects of HMGCR, LPL, and PCSK9 inhibition on sleep apnea: Mendelian randomization analysis of drug targets
  Wei Tan, Xiujuan Deng, Xiaoning Tan, Guangbo Tan
  Medicine.2024; 103(43): e40194.     CrossRef
• Causal association between remnant cholesterol level and risk of cardiovascular diseases: a bidirectional two sample mendelian randomization study
  Lei Zhong, Bo Xie, Hai-Li Wang, Xiao-Wei Ji
  Scientific Reports.2024;[Epub]     CrossRef
• A bibliometric analysis of immunotherapy for atherosclerosis: trends and hotspots prediction
  Jing-Hui Wang, Guan-Rui Pan, Long Jiang
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Liver cancer cells as the model for developing liver-targeted RNAi therapeutics
  Beibei Hou, Linhui Qin, Linfeng Huang
  Biochemical and Biophysical Research Communications.2023; 644: 85.     CrossRef
• Insights into Causal Cardiovascular Risk Factors from Mendelian Randomization
  C. M. Schooling, J. V. Zhao
  Current Cardiology Reports.2023; 25(2): 67.     CrossRef
• Secoisolariciresinol diglucoside and anethole ameliorate lipid abnormalities, oxidative injury, hypercholesterolemia, heart, and liver conditions
  Sana Noreen, Habib‐ur Rehman, Tabussam Tufail, Huma Badar Ul Ain, Chinaza Godswill Awuchi
  Food Science & Nutrition.2023; 11(6): 2620.     CrossRef
• Colesterol remanente, riesgo vascular y prevención de la arteriosclerosis
  Xavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán, Agustín Blanco, Mariano Blasco, José Luís Díaz Díaz, Ángel Díaz Rodríguez, Alipio Mangas, Vicente Pascual, Juan Pedro Botet, Pablo Pérez Martínez
  Clínica e Investigación en Arteriosclerosis.2023; 35(4): 206.     CrossRef
• Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
  Michael J. Wilkinson, Norman E. Lepor, Erin D. Michos
  Journal of the American Heart Association.2023;[Epub]     CrossRef
• The cell origins of foam cell and lipid metabolism regulated by mechanical stress in atherosclerosis
  Zhi Ouyang, Jian Zhong, Junyi Shen, Ye Zeng
  Frontiers in Physiology.2023;[Epub]     CrossRef
• Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
  Alejandro Gugliucci
  Journal of Clinical Medicine.2023; 12(13): 4399.     CrossRef
• Remnant cholesterol, vascular risk, and prevention of atherosclerosis
  Xavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán
  Clínica e Investigación en Arteriosclerosis (English Edition).2023; 35(4): 206.     CrossRef
• Antibiotics and Lipid-Modifying Agents: Potential Drug–Drug Interactions and Their Clinical Implications
  Marios Spanakis, Danny Alon-Ellenbogen, Petros Ioannou, Nikolaos Spernovasilis
  Pharmacy.2023; 11(4): 130.     CrossRef
• Advances in Treatment of Dyslipidemia
  Jill Dybiec, Wiktoria Baran, Bartłomiej Dąbek, Piotr Fularski, Ewelina Młynarska, Ewa Radzioch, Jacek Rysz, Beata Franczyk
  International Journal of Molecular Sciences.2023; 24(17): 13288.     CrossRef
• Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease
  Elena Valeria Fuior, Evangelia Zvintzou, Theodosios Filippatos, Katerina Giannatou, Victoria Mparnia, Maya Simionescu, Anca Violeta Gafencu, Kyriakos E. Kypreos
  Biomedicines.2023; 11(10): 2696.     CrossRef
• Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles
  Lixin Du, Huiling Lu, Yifei Xiao, Zhihua Guo, Ya Li
  Scientific Reports.2023;[Epub]     CrossRef
• Dysregulation of Cholesterol Homeostasis in Ovarian Cancer
  Zahraa Qusairy, Anne Gangloff, Shuk On Annie Leung
  Current Oncology.2023; 30(9): 8386.     CrossRef
• Riesgo residual. Conclusiones
  Ángel Cequier, José Luis Zamorano
  Revista Española de Cardiología Suplementos.2023; 23: 25.     CrossRef
• Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study
  Zilong Tan, Jing Hong, Aochuan Sun, Mengdi Ding, Jianwu Shen
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Bibliometric analysis of residual cardiovascular risk: trends and frontiers
  Lin Wang, Sutong Wang, Chaoyuan Song, Yiding Yu, Yuehua Jiang, Yongcheng Wang, Xiao Li
  Journal of Health, Population and Nutrition.2023;[Epub]     CrossRef
• Current Understanding on the Genetic Basis of Key Metabolic Disorders: A Review
  Kenneth Francis Rodrigues, Wilson Thau Lym Yong, Md. Safiul Alam Bhuiyan, Shafiquzzaman Siddiquee, Muhammad Dawood Shah, Balu Alagar Venmathi Maran
  Biology.2022; 11(9): 1308.     CrossRef
• Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
  Joon Ho Moon, Kyuho Kim, Sung Hee Choi
  Endocrinology and Metabolism.2022; 37(4): 575.     CrossRef

Citations

Citations to this article as recorded by  

• Targeting metabolic dysfunction-associated steatotic liver disease with phytosomal silymarin and piperine: A natural alternative to fenofibrate in a rat model
  Magdy Fouad Tawfik, Yasmin Sayed Hussein, Amany Helmy Hasanin, Walaa Baher, Nashwa El-Khazragy, Farouk Guindi Moawad, Mawada Abou El-Khair, Salwa M. El-Sayed
  Naunyn-Schmiedeberg's Archives of Pharmacology.2026; 399(4): 5559.     CrossRef
• Peroxisomes in Aging: Guardians of Cellular Resilience and Function
  Artuur Vercaemst, Mingming Zhao, Ruizhi Chai, Celien Lismont, Marc Fransen
  Cells.2026; 15(3): 254.     CrossRef
• PEX11B palmitoylation couples peroxisomal dysfunction with Schwann cells fail in diabetic neuropathy
  Yu Mei Yang, Hang Bin Ma, Yue Xiong, Qian Wu, Xiu Kui Gao
  Journal of Biomedical Science.2025;[Epub]     CrossRef
• Fenofibrate promotes erucic acid metabolism by peroxisome enzyme EHHADH activation alleviating high-fat diet–induced steatotic liver disease
  Ming Jin, Rongmi Zhang, Wenwen Xin, Li Sun, Xue Fan, Qian Lu, Luyong Zhang, Zhenzhou Jiang, Qinwei Yu
  Molecular Pharmacology.2025; 107(7): 100047.     CrossRef
• Fenofibrate in Metabolic Dysfunction-associated Steatotic Liver Disease: A Systematic Review and Meta-analysis
  Manoj Kumar, Avivar Awasthi, Deep Dutta, Ameya Joshi, Meha Sharma
  Indian Journal of Endocrinology and Metabolism.2025; 29(3): 268.     CrossRef
• Orchestration of Gut–Liver-Associated Transcription Factors in MAFLD: From Cross-Organ Interactions to Therapeutic Innovation
  Ao Liu, Mengting Huang, Yuwen Xi, Xiaoling Deng, Keshu Xu
  Biomedicines.2025; 13(6): 1422.     CrossRef
• Murine Models of Obesity-Related Cancer Risk
  Lukmon M. Raji, Monowarul M. Siddique, Margaret S. Bohm, Joseph F. Pierre, Mary C. Playdon, Scott A. Summers, Bing Li, Katherine L. Cook, E. Angela Murphy, Liza Makowski
  Cancer Prevention Research.2025; 18(9): 509.     CrossRef
• Myeloid-Specific STAT3 Deletion Aggravates Liver Fibrosis in Mice Fed a Methionine- and Choline-Deficient Diet via Upregulation of Hepatocyte-Derived Lipocalin-2
  Kyung Eun Kim, Hyun Joo Shin, Hyeong Seok An, Eun Ae Jeong, Yundong Sun, Jiwon Oh, Jiwoo Park, Jaewoong Lee, Seung-Soon Im, Gu Seob Roh
  Cells.2025; 14(19): 1522.     CrossRef
• Pharmacological potential of ginseng and ginsenosides in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
  Young-Su Yi
  Journal of Ginseng Research.2024; 48(2): 122.     CrossRef
• Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function
  Xuemei Wang, Jieying Wang, Cao Ying, Yuan Xing, Xuan Su, Ke Men
  BMC Pharmacology and Toxicology.2024;[Epub]     CrossRef
• Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
  Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
  Diabetes & Metabolism Journal.2024; 48(2): 184.     CrossRef
• Lactobacillus plantarum NCHBL-004 modulates high-fat diet–induced weight gain and enhances GLP-1 production for blood glucose regulation
  Ah-Ra Jang, Do-Hyeon Jung, Tae-Sung Lee, Jeon-Kyung Kim, Yu-Bin Lee, Jae-Young Lee, So-Yeon Kim, Yung-Choon Yoo, Jae-Hee Ahn, Eun-Hye Hong, Chae-Won Kim, Su Min Kim, Hye Hyun Yoo, Joo Young Huh, Hyun-Jeong Ko, Jong-Hwan Park
  Nutrition.2024; 128: 112565.     CrossRef
• Peroxisome Proliferator Activator α Agonist Clofibrate Induces Pexophagy in Coconut Oil-Based High-Fat Diet-Fed Rats
  Kanami Ohshima, Emika Hara, Mio Takimoto, Yidan Bai, Mai Hirata, Wen Zeng, Suzuka Uomoto, Mai Todoroki, Mio Kobayashi, Takuma Kozono, Tetsuhito Kigata, Makoto Shibutani, Toshinori Yoshida
  Biology.2024; 13(12): 1027.     CrossRef
• Targeted use of hepatoprotectors for the treatment of various stages of non-alcoholic fatty liver disease (fatty degeneration of the liver according to ICD 10) and associated comorbid conditions; tables for medical use
  L. B. Lazebnik, S. V. Turkina, E. V. Golovanova
  Experimental and Clinical Gastroenterology.2024; (10): 11.     CrossRef
• Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
  Manuela Vitulo, Elisa Gnodi, Giulia Rosini, Raffaella Meneveri, Roberto Giovannoni, Donatella Barisani
  International Journal of Molecular Sciences.2023; 24(16): 12748.     CrossRef
• PPARα agonist fenofibrate prevents postoperative cognitive dysfunction by enhancing fatty acid oxidation in mice
  Tiantian Liu, Xinlu Chen, Ziqi Wei, Xue Han, Yujia Liu, Zhengliang Ma, Tianjiao Xia, Xiaoping Gu
  Translational Neuroscience.2023;[Epub]     CrossRef
• Fenofibrate enhances lipid deposition via modulating PPARγ, SREBP-1c, and gut microbiota in ob/ob mice fed a high-fat diet
  Ying Zhang, Xiu-Bin Jia, Yun-Chao Liu, Wen-Qian Yu, Yan-Hong Si, Shou-Dong Guo
  Frontiers in Nutrition.2022;[Epub]     CrossRef

Fibrates, peroxisome proliferator-activated receptor-α agonists, are potent lipid-modifying drugs. Their main effects are reduction of triglycerides and increase in high-density lipoprotein levels. Several randomized controlled trials have not demonstrated their benefits on cardiovascular risk reduction, especially as an “add on” to statin therapy. However, subsequent analyses by major clinical trials, meta-analyses, and real-world evidence have proposed their potential in specific patient populations with atherogenic dyslipidemia and metabolic syndrome. Here, we have reviewed and discussed the accumulated data on fibrates to understand their current status in cardiovascular risk management.

Citations

Citations to this article as recorded by  

• Continuous Flow Technologies for the Synthesis of Pharmaceutically and Biologically Important Molecules: Update and Analysis
  Yu‐kun Zhang, Eman Fayad, Dalal Nasser Binjawhar, Bing Sun, Hua‐Li Qin
  ChemistrySelect.2026;[Epub]     CrossRef
• Residual Cardiovascular Risk Associated with Non-HDL-C in Statin-Treated Patients: Data from the Gulf Triglyceride and Residual Cardiovascular Risk (Gulf CALLS) Cohort
  Wael Al Mahmeed, Manal Al Kindi, Ahmed Al-Sarraf, Haitham Amin, Mahmoud Zirie, Fatheya Al Awadi, Hani Sabbour, Khalid Al-Waili, Nader Lessan, Alia Al Tikriti, Obada Salameh, Ibrahim Al-Zakwani, Khalid Al-Rasadi
  Angiology.2026;[Epub]     CrossRef
• Estrogen, Epigenetics, and Cardiometabolic Health: Mechanisms and Therapeutic Strategies in Postmenopausal Women
  Ailene Edwards, Pranjal Singh, Vyan Shah, Vivek Chander, Sumita Mishra
  Cells.2026; 15(6): 529.     CrossRef
• Importance and Management of Non–High-Density Lipoprotein Cholesterol in Dyslipidemia Treatment
  Richard C. O’Brien, Lourdes Ella Gonzalez-Santos, Brian Tomlinson, Zanariah Hussein, Soo Lim, Hapizah Nawawi, Hean Yee Ong, Silki Silki, Sidartawan Soegondo, Ta-Chen Su, Apichard Sukonthasarn, Pham Nguyen Vinh
  JACC: Asia.2026; 6(4): 403.     CrossRef
• Management of lipid profile and lipid-lowering therapy in the diabetic population of a primary care center according to cardiovascular risk category (SCORE2-Diabetes vs. SCORE)
  André Cunha, João Pedro Correia, Joana Calheiros Lobo, Francisca Botelho Elias, Pedro Costa Leite, Catarina Brazão, Ana Lucas, Dinis B. Loyens
  Revista Portuguesa de Cardiologia.2026; 45(5): 231.     CrossRef
• Apolipoprotein B-containing lipoproteins in atherogenesis
  Jan Borén, Chris J. Packard, Christoph J. Binder
  Nature Reviews Cardiology.2025; 22(6): 399.     CrossRef
• Effect of Fibrates on Lipoprotein-associated Phospholipase A2 Mass and Activity: A Systematic Review and Meta-analysis of Controlled Clinical Trials
  Luis E. Simental-Mendia, Mario Simental-Mendía, Claudia I. Gamboa-Gomez, Tannaz Jamialahmadi, Amirhossein Sahebkar
  Current Pharmaceutical Design.2025; 31(15): 1205.     CrossRef
• Fatty acid binding proteins-mediated mitochondrial dysfunction in the development of age-related diseases: A review
  Xingxing Ren, Chaoyuan Jin, Qilin Li, Congyi Fu, Yu Fang, Zihang Xu, Zi Liang, Tianshi Wang
  International Journal of Biological Macromolecules.2025; 309: 142913.     CrossRef
• An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease
  Anqi Feng, Ruili Yin, Rong Xu, Baoyu Zhang, Longyan Yang
  Frontiers in Pharmacology.2025;[Epub]     CrossRef
• Novel carboxamide derivatives increase lipoprotein lipase gene expression in endothelial and adipose tissues of triton WR- 1339 induced hyperlipidemic rats
  Suhair Hikmat, Aya Hasan, Lama Hamadneh, Mohammad Alwahsh, Sameer Al-Kouz, Yusuf Al-Hiari, Basmah Al-Jammal, Tariq Al-Qirim, Buthaina Hussein
  Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(10): 14315.     CrossRef
• The approach to triglyceride levels in patients with coronary heart disease
  Ilay Shani, Avishay Elis
  European Journal of Internal Medicine.2025; 139: 106375.     CrossRef
• Effect of adding fenofibrate versus curcumin to glimepiride in patients with type 2 diabetes: a randomized controlled trial
  Eman M. Nada, Nashwa M. El-Gharbawy, Haidy Abbas, Rehab H. Werida
  BMC Pharmacology and Toxicology.2025;[Epub]     CrossRef
• Effects of fibrates on lipid profile: a meta-analysis of randomized controlled trials
  Elena Olmastroni, Federica Galimberti, Sining Xie, Manuela Casula, Alberico L Catapano
  European Atherosclerosis Journal.2025;[Epub]     CrossRef
• Hypertriglyceridemia (triglyceride-rich lipoproteins and their remnants): role in the development of atherosclerotic cardiovascular diseases and control strategy. Opinion of the Expert Committee of the Russian Society of Cardiology, the National Atheroscl
  M. G. Bubnova, M. N. Ezhov, D. M. Aronov, A. S. Galyavich, V. S. Gurevich, D. V. Duplyakov, V. K. Zafiraki, N. S. Karamnova, V. V. Kashtalap, G. A. Konovalov, A. N Meshkov, A. G. Obrezan, A. A. Semenkin, I. V. Sergienko, A. E. Filippov
  Russian Journal of Cardiology.2025; 30(5): 6364.     CrossRef
• Chemical Synthesis, Biological Evaluation, and Cheminformatics Analysis of a Group of Chlorinated Diaryl Sulfonamides: Promising Inhibitors of Cholesteryl Ester Transfer Protein
  Reema Abu Khalaf, Ala’a Lafi, Rima Hajjo, Mahmoud A. Al-Sha'er
  Current Computer-Aided Drug Design.2025; 21(5): 694.     CrossRef
• Characterizing Fenofibrate-Related Renal and Urinary Adverse Events: A Comprehensive Analysis of FDA Adverse Event Reporting System Database
  Li Wang, Xiangyun Jin, YanChun Li
  Clinical Therapeutics.2025; 47(12): 1149.     CrossRef
• Hypertriglyceridemia (triglyceride-rich lipoproteins and their remnants): role in development of atherosclerotic cardiovascular diseases and control strategy consensus statement of the expert Committee of the Russian Society of Cardiology (RSC), the Natio
  Marina G. Bubnova, Marat V. Ezhov, David M. Aronov, Albert S. Galyаvich, Viktor S. Gurevich, Dmitry V. Duplyakov, Vitaliy K. Zafiraki, Natalia S. Karamnova, Vasily V. Kashtalap, Gennady A. Konovalov, Alexey N. Meshkov, Andrey G. Obrezan, Alexander A. Seme
  CardioSomatics.2025; 16(3): 192.     CrossRef
• 2025: The year in cardiovascular disease – the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?
  Peter P. Toth, Maciej Banach
  Archives of Medical Science.2025; 21(6): 2229.     CrossRef
• Associations of omega-3 fatty acids vs. fenofibrate with adverse cardiovascular outcomes in people with metabolic syndrome: propensity matched cohort study
  Nam Hoon Kim, Ji Yoon Kim, Jimi Choi, Sin Gon Kim
  European Heart Journal - Cardiovascular Pharmacotherapy.2024; 10(2): 118.     CrossRef
• Role of PPARα in inflammatory response of C2C12 myotubes
  Yuki Shimizu, Keiko Hamada, Tingting Guo, Chie Hasegawa, Yusuke Kuga, Katsushi Takeda, Takashi Yagi, Hiroyuki Koyama, Hiroshi Takagi, Daisuke Aotani, Hiromi Kataoka, Tomohiro Tanaka
  Biochemical and Biophysical Research Communications.2024; 694: 149413.     CrossRef
• Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
  John J. P. Kastelein, Andrew Hsieh, Mary R. Dicklin, Marc Ditmarsch, Michael H. Davidson
  Current Atherosclerosis Reports.2024; 26(2): 35.     CrossRef
• Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases
  Virginia Actis Dato, Stephan Lange, Yoshitake Cho
  International Journal of Molecular Sciences.2024; 25(2): 1211.     CrossRef
• ApoB100 and Atherosclerosis: What’s New in the 21st Century?
  Dimitris Kounatidis, Natalia G. Vallianou, Aikaterini Poulaki, Angelos Evangelopoulos, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela, Maria Dalamaga
  Metabolites.2024; 14(2): 123.     CrossRef
• Follistatin-like 1 (FSTL1) levels as potential early biomarker of cardiovascular disease in a Mexican population
  N. Ponce-Ruíz, J. F. Herrera-Moreno, A. E. Rojas-García, B. S. Barrón-Vivanco, C. A. González-Arias, Y. Y. Bernal-Hernández, L. Ortega-Cervantes, J. Ponce-Gallegos, J. A. Hernández-Nolasco, I. M. Medina-Díaz
  Heart and Vessels.2024; 39(6): 563.     CrossRef
• Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
  Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
  Diabetes & Metabolism Journal.2024; 48(2): 184.     CrossRef
• Coenzyme Q10 in atherosclerosis
  Minjun Liao, Xueke He, Yangyang Zhou, Weiqiang Peng, Xiao-Mei Zhao, Miao Jiang
  European Journal of Pharmacology.2024; 970: 176481.     CrossRef
• Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study
  Maria Paravati, Anna Procopio, Maja Milanović, Giuseppe Scarlata, Nataša Milošević, Maja Ružić, Nataša Milić, Ludovico Abenavoli
  Nutrients.2024; 16(8): 1226.     CrossRef
• Therapeutic approach in the treatment of dyslipidemia: Novelties and challenges
  Katarina Lalić, Nataša Rajković, Ljiljana Popović, Sandra Singh-Lukač, Iva Rasulić, Ana Petakov, Milica Krstić, Marija Mitrović
  Galenika Medical Journal.2024; 3(9): 31.     CrossRef
• Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis
  Quankai Cheng, Jingjing Sun, Haicheng Zhong, Ziming Wang, Chang Liu, Sheng Zhou, Jie Deng
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Expression of FAM159B in Humans, Rats, and Mice: A Cross-species Examination
  Anna-Sophia Liselott Beyer, Daniel Kaemmerer, Jörg Sänger, Amelie Lupp
  Journal of Histochemistry & Cytochemistry.2024; 72(7): 467.     CrossRef
• The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
  Dimitris Kounatidis, Nikolaos Tentolouris, Natalia G. Vallianou, Iordanis Mourouzis, Irene Karampela, Theodora Stratigou, Eleni Rebelos, Marina Kouveletsou, Vasileios Stamatopoulos, Eleni Tsaroucha, Maria Dalamaga
  Metabolites.2024; 14(7): 388.     CrossRef
• Fenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study
  Sangmo Hong, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• The role of DGAT1 and DGAT2 in tumor progression via fatty acid metabolism: A comprehensive review
  Leisheng Wang, Shiwei Xu, Mengzhen Zhou, Hao Hu, Jinyou Li
  International Journal of Biological Macromolecules.2024; 278: 134835.     CrossRef
• Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factor
  Nam Hoon Kim, Juneyoung Lee, Suk Chon, Jae Myung Yu, In-Kyung Jeong, Soo Lim, Won Jun Kim, Keeho Song, Ho Chan Cho, Hea Min Yu, Kyoung-Ah Kim, Sang Soo Kim, Soon Hee Lee, Chong Hwa Kim, Soo Heon Kwak, Yong‐ho Lee, Choon Hee Chung, Sihoon Lee, Heung Yong J
  Endocrinology and Metabolism.2024; 39(5): 722.     CrossRef
• Safety and Efficacy of the Novel RNA Interference Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis
  A.B.M. Kamrul-Hasan, Deep Dutta, Lakshmi Nagendra, Sunetra Mondal, Saptarshi Bhattacharya, Sanjay Kalra
  Endocrine Practice.2024; 30(11): 1103.     CrossRef
• Effects of Fatty Acid Metabolism on Heart Failure
  日娜 萨
  Advances in Clinical Medicine.2024; 14(09): 787.     CrossRef
• Revisiting PPAR agonists: novel perspectives in the treatment of primary biliary cholangitis
  Yiran Chen, Kunyu Zheng, Gahu Da, Xu Wang, Yi Wei, Guochun Wang, Fengchun Zhang, Li Wang
  Expert Opinion on Pharmacotherapy.2024; 25(13): 1825.     CrossRef
• Integrated review of cardiometabolic biomarkers and dietary nutrients
  Ravindra Verma, Prakash S Bisen, Mònica Bulló
  Journal of Food Bioactives.2024; : 44.     CrossRef
• Cardiovascular Diseases and Metabolic Medications in the Lebanese Population: A Post Hoc Analysis from a Nationwide Cross-Sectional Study
  Rony M. Zeenny, Rachel Abdo, Chadia Haddad, Aline Hajj, Rouba Karen Zeidan, Pascale Salameh, Jean Ferrieres
  Pharmacy.2024; 12(6): 171.     CrossRef
• From Adipose to Ailing Kidneys: The Role of Lipid Metabolism in Obesity-Related Chronic Kidney Disease
  Wenchao Xu, Yuting Zhu, Siyuan Wang, Jihong Liu, Hao Li
  Antioxidants.2024; 13(12): 1540.     CrossRef
• Exploring the mechanism of fibrates regulating HIF-1A in the treatment of ischemic stroke based on network pharmacology and molecular docking
  Fengjiao Yang, Zixuan Yang, Ya Yan, Yun Gu, Pengyu Wang, Min Wang, Jianjie Chen, Xiaoshan Du, Guangming Wang
  BMC Research Notes.2024;[Epub]     CrossRef
• Present and Future of Dyslipidaemia Treatment—A Review
  Iveta Merćep, Andro Vujević, Dominik Strikić, Ivana Radman, Ivan Pećin, Željko Reiner
  Journal of Clinical Medicine.2023; 12(18): 5839.     CrossRef
• VLDL receptor gene therapy for reducing atherogenic lipoproteins
  Ronald M. Krauss, Jonathan T. Lu, Joseph J. Higgins, Cathryn M. Clary, Ray Tabibiazar
  Molecular Metabolism.2023; 69: 101685.     CrossRef
• The emerging role of PPAR-alpha in breast cancer
  Zhiwen Qian, Lingyan Chen, Jiayu Liu, Ying Jiang, Yan Zhang
  Biomedicine & Pharmacotherapy.2023; 161: 114420.     CrossRef
• Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease
  Yujie Pu, Chak Kwong Cheng, Hongsong Zhang, Jiang‐Yun Luo, Li Wang, Brian Tomlinson, Yu Huang
  Medicinal Research Reviews.2023; 43(6): 2086.     CrossRef
• Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism
  DuoYao Cao, Zakir Khan, Xiaomo Li, Suguru Saito, Ellen A Bernstein, Aaron R Victor, Faizan Ahmed, Aoi O Hoshi, Luciana C Veiras, Tomohiro Shibata, Mingtian Che, Lei Cai, Michifumi Yamashita, Ryan E Temel, Jorge F Giani, Daniel J Luthringer, Ajit S Divakar
  Cardiovascular Research.2023; 119(9): 1825.     CrossRef
• Rapid flow synthesis of fenofibrate via scalable flash chemistry with in-line Li recovery
  Sanket A. Kawale, Dong-Chang Kang, Gwang-Noh Ahn, Amirreza Mottafegh, Ji-Ho Kang, Gi-Su Na, Dong-Pyo Kim
  Chemical Engineering Journal.2023; 477: 147033.     CrossRef
• Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome
  Marat V. Ezhov, Gregory P. Arutyunov
  Diseases.2023; 11(4): 140.     CrossRef
• Development of New Genome Editing Tools for the Treatment of Hyperlipidemia
  Giulio Preta
  Cells.2023; 12(20): 2466.     CrossRef
• Exploring the hypolipidemic effects of bergenin from Saxifraga melanocentra Franch: mechanistic insights and potential for hyperlipidemia treatment
  Li Zhang, Yingying Tong, Yan Fang, Jinjin Pei, Qilan Wang, Gang Li
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Obesity and Dyslipidemia
  Barbora Nussbaumerova, Hana Rosolova
  Current Atherosclerosis Reports.2023; 25(12): 947.     CrossRef
• Bibliometric analysis of residual cardiovascular risk: trends and frontiers
  Lin Wang, Sutong Wang, Chaoyuan Song, Yiding Yu, Yuehua Jiang, Yongcheng Wang, Xiao Li
  Journal of Health, Population and Nutrition.2023;[Epub]     CrossRef
• Hypertriglyceridemia in Apoa5–/– mice results from reduced amounts of lipoprotein lipase in the capillary lumen
  Ye Yang, Anne P. Beigneux, Wenxin Song, Le Phuong Nguyen, Hyesoo Jung, Yiping Tu, Thomas A. Weston, Caitlyn M. Tran, Katherine Xie, Rachel G. Yu, Anh P. Tran, Kazuya Miyashita, Katsuyuki Nakajima, Masami Murakami, Yan Q. Chen, Eugene Y. Zhen, Joonyoung R.
  Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update
  Dipali Kale, Amol Fatangare, Prasad Phapale, Albert Sickmann
  Cells.2023; 12(24): 2796.     CrossRef
• Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia
  Gary F Lewis, Robert A Hegele
  The Lancet Diabetes & Endocrinology.2022; 10(2): 142.     CrossRef
• Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study
  Thomas Metzner, Deborah R. Leitner, Karin Mellitzer, Andrea Beck, Harald Sourij, Tatjana Stojakovic, Gernot Reishofer, Winfried März, Ulf Landmesser, Hubert Scharnagl, Hermann Toplak, Günther Silbernagel
  Biomedicines.2022; 10(1): 193.     CrossRef
• Is there a role of lipid-lowering therapies in the management of fatty liver disease?
  Ismini Tzanaki, Aris P Agouridis, Michael S Kostapanos
  World Journal of Hepatology.2022; 14(1): 119.     CrossRef
• Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?
  Ana Clara Aprotosoaie, Alexandru-Dan Costache, Irina-Iuliana Costache
  Pharmaceutics.2022; 14(4): 722.     CrossRef
• The Overlooked Transformation Mechanisms of VLCFAs: Peroxisomal β-Oxidation
  Qinyue Lu, Weicheng Zong, Mingyixing Zhang, Zhi Chen, Zhangping Yang
  Agriculture.2022; 12(7): 947.     CrossRef
• Current Trends of Big Data Research Using the Korean National Health Information Database
  Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
  Diabetes & Metabolism Journal.2022; 46(4): 552.     CrossRef
• New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
  Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
  Diabetes & Metabolism Journal.2022; 46(4): 517.     CrossRef
• Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure
  Agata Jedrzejewska, Alicja Braczko, Ada Kawecka, Marcin Hellmann, Piotr Siondalski, Ewa Slominska, Barbara Kutryb-Zajac, Magdi H. Yacoub, Ryszard T. Smolenski
  International Journal of Molecular Sciences.2022; 23(17): 9886.     CrossRef
• Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
  Joon Ho Moon, Kyuho Kim, Sung Hee Choi
  Endocrinology and Metabolism.2022; 37(4): 575.     CrossRef
• Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
  Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
  Metabolism.2022; 137: 155327.     CrossRef
• Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
  Veronika Vyletelová, Mária Nováková, Ľudmila Pašková
  Pharmaceuticals.2022; 15(10): 1278.     CrossRef
• Cardiovascular Risk Profile and Lipid Management in the Population-Based Cohort Study LATINO: 20 Years of Real-World Data
  Cristina Gavina, Daniel Seabra Carvalho, Marisa Pardal, Marta Afonso-Silva, Diana Grangeia, Ricardo Jorge Dinis-Oliveira, Francisco Araújo, Tiago Taveira-Gomes
  Journal of Clinical Medicine.2022; 11(22): 6825.     CrossRef
• New and Emerging lipid-lowering Therapy
  James M Backes, Daniel E Hilleman
  Future Cardiology.2021; 17(8): 1407.     CrossRef
• Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
  Styliani Fragki, Hubert Dirven, Tony Fletcher, Bettina Grasl-Kraupp, Kristine Bjerve Gützkow, Ron Hoogenboom, Sander Kersten, Birgitte Lindeman, Jochem Louisse, Ad Peijnenburg, Aldert H. Piersma, Hans M. G. Princen, Maria Uhl, Joost Westerhout, Marco J. Z
  Critical Reviews in Toxicology.2021; 51(2): 141.     CrossRef
• A network pharmacology analysis on drug‐like compounds from Ganoderma lucidum for alleviation of atherosclerosis
  Ki Kwang Oh, Md. Adnan, Dong Ha Cho
  Journal of Food Biochemistry.2021;[Epub]     CrossRef
• Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study
  Myung Soo Park, Jong-Chan Youn, Eung Ju Kim, Ki Hoon Han, Sang Hak Lee, Sung Hea Kim, Byung Jin Kim, Sung Uk Kwon, Kyu-Hyung Ryu
  Clinical Therapeutics.2021; 43(10): 1735.     CrossRef
• Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany
  Louis Jacob, Roger-Axel Greiner, Mark Luedde, Karel Kostev
  Journal of Cardiovascular Pharmacology.2021; 78(6): 885.     CrossRef
• Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature
  Leili Rahimi, Mojtaba Malek, Faramarz Ismail-Beigi, Mohammad E. Khamseh
  Advances in Therapy.2020; 37(8): 3450.     CrossRef
• Treatment With Gemfibrozil Prevents the Progression of Chronic Kidney Disease in Obese Dahl Salt-Sensitive Rats
  Corbin A. Shields, Bibek Poudel, Kasi C. McPherson, Andrea K. Brown, Ubong S. Ekperikpe, Evan Browning, Lamari Sutton, Denise C. Cornelius, Jan M. Williams
  Frontiers in Physiology.2020;[Epub]     CrossRef
• Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes
  Amelia Charlton, Jessica Garzarella, Karin A. M. Jandeleit-Dahm, Jay C. Jha
  Biology.2020; 10(1): 18.     CrossRef

Citations

Citations to this article as recorded by  

• Lipocalin‐2—The myth of its expression and function
  Dahui Li, Wai Yan Sun, Bowen Fu, Aimin Xu, Yu Wang
  Basic & Clinical Pharmacology & Toxicology.2020; 127(2): 142.     CrossRef
• Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes
  Ioanna Mosialou, Steven Shikhel, Na Luo, Peristera Ioanna Petropoulou, Konstantinos Panitsas, Brygida Bisikirska, Nyanza J. Rothman, Roxane Tenta, Bertrand Cariou, Matthieu Wargny, Elisabeth Sornay-Rendu, Thomas Nickolas, Mishaela Rubin, Cyrille B. Confav
  Journal of Experimental Medicine.2020;[Epub]     CrossRef
• Metabolism and adult neurogenesis: Towards an understanding of the role of lipocalin-2 and iron-related oxidative stress
  Ana Catarina Ferreira, Nuno Sousa, João M. Bessa, João Carlos Sousa, Fernanda Marques
  Neuroscience & Biobehavioral Reviews.2018; 95: 73.     CrossRef
• LH-21, A Peripheral Cannabinoid Receptor 1 Antagonist, Exerts Favorable Metabolic Modulation Including Antihypertensive Effect in KKAy Mice by Regulating Inflammatory Cytokines and Adipokines on Adipose Tissue
  Ziqi Dong, Hui Gong, Yadan Chen, Hong Wu, Jun Wu, Yinghong Deng, Xinmao Song
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Lipocalin 2 produces insulin resistance and can be upregulated by glucocorticoids in human adipose tissue
  Prasad G. Kamble, Maria J. Pereira, Cherno O. Sidibeh, Sam Amini, Magnus Sundbom, Joey Lau Börjesson, Jan W. Eriksson
  Molecular and Cellular Endocrinology.2016; 427: 124.     CrossRef
• Serum lipocalin-2 levels are positively associated with not only total body fat but also visceral fat area in Chinese men
  Yuqi Luo, Xiaojing Ma, Xiaoping Pan, Yiting Xu, Qin Xiong, Yunfeng Xiao, Yuqian Bao, Weiping Jia
  Medicine.2016; 95(30): e4039.     CrossRef
• From the periphery to the brain: Lipocalin-2, a friend or foe?
  Ana C. Ferreira, Sandro Dá Mesquita, João C. Sousa, Margarida Correia-Neves, Nuno Sousa, Joana A. Palha, Fernanda Marques
  Progress in Neurobiology.2015; 131: 120.     CrossRef

Adipose tissue, which was once viewed as a simple organ for storage of triglycerides, is now considered an important endocrine organ. Abnormal adipose tissue mass is associated with defects in endocrine and metabolic functions which are the underlying causes of the metabolic syndrome. Many adipokines, hormones secreted by adipose tissue, regulate cells from the immune system. Interestingly, most of these adipokines are proinflammatory mediators, which increase dramatically in the obese state and are believed to be involved in the pathogenesis of insulin resistance. Drugs that target peroxisome proliferator-activated receptor-γ have been shown to possess anti-inflammatory effects in animal models of diabetes. These findings, and the link between inflammation and the metabolic syndrome, will be reviewed here.

Citations

Citations to this article as recorded by  

• Molecular Mechanisms of Herbal Drugs in Modulating Insulin Resistance: Focus on AMPK, PPARs, and mTOR Pathways
  Prachi Goswami, Garima Mathur, Shivani Sharma, Devika Gautam, Kalpana Swain, Satyanarayan Pattnaik
  Current Pharmacology Reports.2026;[Epub]     CrossRef
• Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches
  Benson M. Hamooya, Lukundo Siame, Lweendo Muchaili, Sepiso K. Masenga, Annet Kirabo
  Frontiers in Nutrition.2025;[Epub]     CrossRef
• Structure Meets Function: Dissecting Fucoxanthin’s Bioactive Architecture
  Patrícia Nogueira, Victória Bombarda-Rocha, Rita Tavares-Henriques, Mariana Carneiro, Emília Sousa, Jorge Gonçalves, Paula Fresco
  Marine Drugs.2025; 23(11): 440.     CrossRef
• Lysine 222 in PPAR γ1 functions as the key site of MuRF2-mediated ubiquitination modification
  Yucheng Fan, Fangjing Xu, Rui Wang, Jun He
  Scientific Reports.2023;[Epub]     CrossRef
• Heart failure and diabetes: Clinical significance and epidemiology of this two‐way association
  Terri Jerkins, Janet B. McGill, David S. H. Bell
  Diabetes, Obesity and Metabolism.2023; 25(S3): 3.     CrossRef
• The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics
  Gargi Dixit, Arati Prabhu
  Experimental and Molecular Pathology.2022; 124: 104723.     CrossRef
• The Effect of PPARγ rs1801282 Variant on Mortality Risk Among Asians With Chronic Kidney Disease: A Cohort Study and Meta-Analysis
  Wei-Teing Chen, Chih-Chien Chiu, Dung-Jang Tsai, Pi-Shao Ko, Meng-Chang Lee, Hsiao-Ting Lin, Ying-Kai Chen, Wen Su, Yuh-Feng Lin, Sui-Lung Su
  Frontiers in Genetics.2022;[Epub]     CrossRef
• Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
  Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh
  International Journal of Molecular Sciences.2021; 22(9): 4495.     CrossRef
• Associations between obesity-related gene expression in maternal and cord blood and newborn adiposity: findings from the Araraquara Cohort study
  P. Nakandakare, C. F. Nicoletti, N. Y. Noronha, C. B. Nonino, P. P. Argentato, N. N. Dejani, L. A. Luzia, M. M. Rogero, P. H. C. Rondó
  International Journal of Obesity.2021; 45(9): 1958.     CrossRef
• PPARG Pro12Ala Polymorphism with CKD in Asians: A Meta-Analysis Combined with a Case-Control Study—A Key for Reaching Null Association
  Hsiang-Cheng Chen, Wei-Teing Chen, Tzu-Ling Sung, Dung-Jang Tsai, Chin Lin, Hao Su, Yuh-Feng Lin, Hung-Yi Chiu, Sui-Lung Su
  Genes.2020; 11(6): 705.     CrossRef
• Induction of peroxisome proliferator activated receptor γ (PPARγ) mediated gene expression and inhibition of induced nitric oxide production by Maerua subcordata (Gilg) DeWolf
  Mebrahtom Gebrelibanos Hiben, Laura de Haan, Bert Spenkelink, Sebastiaan Wesseling, Jacques Vervoort, Ivonne M. C. M. Rietjens
  BMC Complementary Medicine and Therapies.2020;[Epub]     CrossRef
• UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis
  Brahmchetna Bedi, Kuo-Chuan. Lin, Nicholas M. Maurice, Zhihong Yuan, Kaiser Bijli, Michael Koval, C. Michael Hart, Joanna B. Goldberg, Arlene Stecenko, Ruxana T. Sadikot
  Clinical Science.2020; 134(14): 1911.     CrossRef
• Sepsis Immunometabolism: From Defining Sepsis to Understanding How Energy Production Affects Immune Response
  Ioannis Koutroulis, Rachael Batabyal, Brittany McNamara, Matthew Ledda, Claire Hoptay, Robert J. Freishtat
  Critical Care Explorations.2019; 1(11): e0061.     CrossRef
• Combining SGLT2 Inhibition With a Thiazolidinedione Additively Attenuate the Very Early Phase of Diabetic Nephropathy Progression in Type 2 Diabetes Mellitus
  Eugene Han, Eugene Shin, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Role of oral hypoglycemic drugs on inflammatory condition associated with type 2 diabetes mellitus
  Shamim Shaikh Mohiuddin
  Journal of Diabetes, Metabolic Disorders & Control.2018; 5(2): 78.     CrossRef
• Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice
  Bong-Hoi Choi, Zhen Jin, Chin-ok Yi, Juhong Oh, Eun Ae Jeong, Jong Youl Lee, Kyung-ah Park, Kyung Eun Kim, Jung Eun Lee, Hyun-Jin Kim, Jong Ryeal Hahm, Gu Seob Roh, Jonathan M Peterson
  PLOS ONE.2018; 13(7): e0200336.     CrossRef
• Cucurbita ficifolia (Cucurbitaceae) modulates inflammatory cytokines and IFN-γ in obese mice
  Á. Fortis-Barrera, R. García-Macedo, J.C. Almanza-Perez, G. Blancas-Flores, A. Zamilpa-Alvarez, J.L. Flores-Sáenz, M. Cruz, R. Román-Ramos, F.J. Alarcón-Aguilar
  Canadian Journal of Physiology and Pharmacology.2017; 95(2): 170.     CrossRef
• Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
  Yong-ho Lee, Jae Hyeon Kim, So Ra Kim, Heung Yong Jin, Eun-Jung Rhee, Young Min Cho, Byung-Wan Lee
  Journal of Korean Medical Science.2017; 32(1): 60.     CrossRef
• Peroxisome proliferator‐activated receptor‐γ agonists attenuate biofilm formation by Pseudomonas aeruginosa
  Brahmchetna Bedi, Nicholas M. Maurice, Vincent T. Ciavatta, K. Sabrina Lynn, Zhihong Yuan, Samuel A. Molina, Myungsoo Joo, William R. Tyor, Joanna B. Goldberg, Michael Koval, C. Michael Hart, Ruxana T. Sadikot
  The FASEB Journal.2017; 31(8): 3608.     CrossRef
• Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
  Marit de Jong, H. Bart van der Worp, Yolanda van der Graaf, Frank L. J. Visseren, Jan Westerink
  Cardiovascular Diabetology.2017;[Epub]     CrossRef
• Gestational diabetes mellitus was related to ambient air pollutant nitric oxide during early gestation
  Shih-Chun Pan, Ching-Chun Huang, Shio-Jean Lin, Bing-Yu Chen, Chang-Chuan Chan, Yue-Liang Leon Guo
  Environmental Research.2017; 158: 318.     CrossRef
• The Multifaceted Haptoglobin in the Context of Adipose Tissue and Metabolism
  Margherita Maffei, Ilaria Barone, Gaia Scabia, Ferruccio Santini
  Endocrine Reviews.2016; 37(4): 403.     CrossRef
• Enhanced Clearance of Pseudomonas aeruginosa by Peroxisome Proliferator-Activated Receptor Gamma
  Brahmchetna Bedi, Zhihong Yuan, Myungsoo Joo, Susu M. Zughaier, Joanna B. Goldberg, Jack L. Arbiser, C. Michael Hart, Ruxana T. Sadikot, B. A. McCormick
  Infection and Immunity.2016; 84(7): 1975.     CrossRef
• F-box only protein 9 is an E3 ubiquitin ligase of PPARγ
  Kyeong Won Lee, Soo Heon Kwak, Young Do Koo, Yun-Kyung Cho, Hak Mo Lee, Hye Seung Jung, Young Min Cho, Young Joo Park, Sung Soo Chung, Kyong Soo Park
  Experimental & Molecular Medicine.2016; 48(5): e234.     CrossRef
• The Resin fromProtium heptaphyllumPrevents High-Fat Diet-Induced Obesity in Mice: Scientific Evidence and Potential Mechanisms
  Karine Maria Martins Bezerra Carvalho, José Delano Barreto Marinho Filho, Tiago Sousa de Melo, Ana Jérsia Araújo, Josiane da Silva Quetz, Maria do Perpétuo Socorro Saldanha da Cunha, Karina Moura de Melo, Armenio Andre de Carvalho Almeida da Silva, Adrian
  Evidence-Based Complementary and Alternative Medicine.2015; 2015: 1.     CrossRef
• Lobeglitazone and pioglitazone as add‐ons to metformin for patients with type 2 diabetes: a 24‐week, multicentre, randomized, double‐blind, parallel‐group, active‐controlled, phase III clinical trial with a 28‐week extension
  S.‐M. Jin, C.‐Y. Park, Y. M. Cho, B. J. Ku, C. W. Ahn, B.‐S. Cha, K. W. Min, Y. A. Sung, S. H. Baik, K. W. Lee, K.‐H. Yoon, M.‐K. Lee, S. W. Park
  Diabetes, Obesity and Metabolism.2015; 17(6): 599.     CrossRef
• Deconvolution of Complex 1D NMR Spectra Using Objective Model Selection
  Travis S. Hughes, Henry D. Wilson, Ian Mitchelle S. de Vera, Douglas J. Kojetin, Paul C. Driscoll
  PLOS ONE.2015; 10(8): e0134474.     CrossRef
• PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes
  Flora Aparecida Milton, Aleksandra Cvoro, Angelica A. Amato, Douglas H. Sieglaff, Carly S. Filgueira, Anithachristy Sigamani Arumanayagam, Maria do Carmo Alves de Lima, Ivan Rocha Pitta, Francisco de Assis Rocha Neves, Paul Webb
  Biochemical and Biophysical Research Communications.2015; 464(3): 718.     CrossRef
• Voluntary exercise prevents colonic inflammation in high-fat diet-induced obese mice by up-regulating PPAR-γ activity
  Wei-Xin Liu, Ting Wang, Feng Zhou, Ying Wang, Jun-Wei Xing, Shen Zhang, Shou-Zhi Gu, Li-Xuan Sang, Cong Dai, Hai-Lan Wang
  Biochemical and Biophysical Research Communications.2015; 459(3): 475.     CrossRef
• Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis
  Soo Lim, Kuy-Sook Lee, Jie Eun Lee, Ho Seon Park, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Kyong Soo Park, Young Bum Kim, Hak Chul Jang
  Atherosclerosis.2015; 243(1): 107.     CrossRef
• Antidiabetic agents: Potential anti-inflammatory activity beyond glucose control
  A.J. Scheen, N. Esser, N. Paquot
  Diabetes & Metabolism.2015; 41(3): 183.     CrossRef
• Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein
  Yanxiao Zhang, Jingcheng Yu, Chee Lee, Bin Xu, Maureen A. Sartor, Ronald J. Koenig
  Oncotarget.2015; 6(38): 40418.     CrossRef
• Peroxisome Proliferator-Activated Receptor γ (PPARγ) and Ligand Choreography: Newcomers Take the Stage
  Santiago Garcia-Vallvé, Laura Guasch, Sarah Tomas-Hernández, Josep Maria del Bas, Vincent Ollendorff, Lluís Arola, Gerard Pujadas, Miquel Mulero
  Journal of Medicinal Chemistry.2015; 58(14): 5381.     CrossRef
• Pathway Analysis of Metabolic Syndrome Using a Genome-Wide Association Study of Korea Associated Resource (KARE) Cohorts
  Unjin Shim, Han-Na Kim, Yeon-Ah Sung, Hyung-Lae Kim
  Genomics & Informatics.2014; 12(4): 195.     CrossRef
• Pax-8–PPAR-γ fusion protein in thyroid carcinoma
  Priyadarshini Raman, Ronald J. Koenig
  Nature Reviews Endocrinology.2014; 10(10): 616.     CrossRef
• Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients: a systemic review and meta-analysis
  Shinan Yin, Hua Bai, Danqing Jing
  Diagnostic Pathology.2014;[Epub]     CrossRef
• Common biological mechanisms between bipolar disorder and type 2 diabetes: Focus on inflammation
  Ajaykumar N. Sharma, Isabelle E. Bauer, Marsal Sanches, Juan F. Galvez, Giovana B. Zunta-Soares, Joao Quevedo, Flavio Kapczinski, Jair C. Soares
  Progress in Neuro-Psychopharmacology and Biological Psychiatry.2014; 54: 289.     CrossRef

Citations

Citations to this article as recorded by  

• Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation
  Bodo Haas, Moritz David Sebastian Hass, Alexander Voltz, Matthias Vogel, Julia Walther, Arijit Biswas, Daniela Hass, Alexander Pfeifer
  Molecular Metabolism.2024; 85: 101956.     CrossRef
• Chitosan-Encapsulated Nano-selenium Targeting TCF7L2, PPARγ, and CAPN10 Genes in Diabetic Rats
  Omayma A. R. Abozaid, Sawsan M. El-Sonbaty, Neama M. A. Hamam, Moustafa A. Farrag, Ahmad S. Kodous
  Biological Trace Element Research.2023; 201(1): 306.     CrossRef
• Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus
  Ayesha Fauzi, Ewen Se Thoe, Tang Yin Quan, Adeline Chia Yoke Yin
  Journal of Diabetes and its Complications.2023; 37(11): 108629.     CrossRef
• Novel Sulfonanilide Inhibitors of SHIP2 Enhance Glucose Uptake into Cultured Myotubes
  Mika E. A. Berg, Jette-Britt Naams, Laura C. Hautala, Tuomas A. Tolvanen, Jari P. Ahonen, Sanna Lehtonen, Kristiina Wähälä
  ACS Omega.2020; 5(3): 1430.     CrossRef
• Diabetic Theory in Anti-Alzheimer’s Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents
  Agnieszka Jankowska, Anna Wesołowska, Maciej Pawłowski, Grażyna Chłoń-Rzepa
  Current Medicinal Chemistry.2020; 27(39): 6658.     CrossRef
• Moringa concanensis Nimmo extracts ameliorates hyperglycemia-mediated oxidative stress and upregulates PPARγ and GLUT4 gene expression in liver and pancreas of streptozotocin-nicotinamide induced diabetic rats
  Brindha Banu Balakrishnan, Kalaivani Krishnasamy, Vijayakumar Mayakrishnan, Arokiyaraj Selvaraj
  Biomedicine & Pharmacotherapy.2019; 112: 108688.     CrossRef
• PPARγ Agonistic Activity of Sulphonylureas
  Debjani Banerjee, Harnovdeep Singh Bharaj, Moulinath Banerjee
  Endocrine, Metabolic & Immune Disorders - Drug Targets.2019; 19(4): 467.     CrossRef
• Glimepiride treatment in a patient with type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene
  Zhimin Huang, Juan Liu, Kaka Ng, Xuesi Wan, Lijuan Xu, Xiaoying He, Zhihong Liao, Yanbing Li
  Journal of Diabetes Investigation.2018; 9(5): 1075.     CrossRef
• Arsenic, Cadmium, and Lead Like Troglitazone Trigger PPARγ-Dependent Poly (ADP-Ribose) Polymerase Expression and Subsequent Apoptosis in Rat Brain Astrocytes
  Rajesh Kushwaha, Juhi Mishra, Sachin Tripathi, Puneet Khare, Sanghamitra Bandyopadhyay
  Molecular Neurobiology.2018; 55(3): 2125.     CrossRef
• Docosahexaenoic acid up‐regulates both PI3K/AKT‐dependent FABP7–PPARγ interaction and MKP3 that enhance GFAP in developing rat brain astrocytes
  Sachin Tripathi, Rajesh Kushwaha, Juhi Mishra, Manoj Kumar Gupta, Harish Kumar, Somali Sanyal, Dhirendra Singh, Sabyasachi Sanyal, Amogh Anant Sahasrabuddhe, Mohan Kamthan, Mohana Krishna Reddy Mudiam, Sanghamitra Bandyopadhyay
  Journal of Neurochemistry.2017; 140(1): 96.     CrossRef
• Antiglycation and cell protective actions of metformin and glipizide in erythrocytes and monocytes
  Krishna Adeshara, Rashmi Tupe
  Molecular Biology Reports.2016; 43(3): 195.     CrossRef
• The therapeutic journey of pyridazinone
  Wasim Akhtar, M. Shaquiquzzaman, Mymoona Akhter, Garima Verma, Mohemmed Faraz Khan, M. Mumtaz Alam
  European Journal of Medicinal Chemistry.2016; 123: 256.     CrossRef
• Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect
  Chetna Kharbanda, Mohammad Sarwar Alam, Hinna Hamid, Kalim Javed, Abhijeet Dhulap, Sameena Bano, Yakub Ali
  Bioorganic & Medicinal Chemistry Letters.2015; 25(20): 4601.     CrossRef
• Method Development and Validation of Amlodipine, Gliquidone and Pioglitazone: Application in the Analysis of Human Serum
  Agha Zeeshan Mirza, M. Saeed Arayne, Najma Sultana
  Analytical Chemistry Letters.2014; 4(5-6): 302.     CrossRef
• Gliquidone decreases urinary protein by promoting tubular reabsorption in diabetic Goto-Kakizaki rats
  Jian-Ting Ke, Mi Li, Shi-Qing Xu, Wen-Jian Zhang, Yong-Wei Jiang, Lan-yun Cheng, Li Chen, Jin-Ning Lou, Wei Wu
  Journal of Endocrinology.2014; 220(2): 129.     CrossRef
• Extension of Drosophila lifespan by cinnamon through a sex-specific dependence on the insulin receptor substrate chico
  Samuel E. Schriner, Steven Kuramada, Terry E. Lopez, Stephanie Truong, Andrew Pham, Mahtab Jafari
  Experimental Gerontology.2014; 60: 220.     CrossRef
• Crif1 Deficiency Reduces Adipose OXPHOS Capacity and Triggers Inflammation and Insulin Resistance in Mice
  Min Jeong Ryu, Soung Jung Kim, Yong Kyung Kim, Min Jeong Choi, Surendar Tadi, Min Hee Lee, Seong Eun Lee, Hyo Kyun Chung, Saet Byel Jung, Hyun-Jin Kim, Young Suk Jo, Koon Soon Kim, Sang-Hee Lee, Jin Man Kim, Gi Ryang Kweon, Ki Cheol Park, Jung Uee Lee, Yo
  PLoS Genetics.2013; 9(3): e1003356.     CrossRef
• Glimepiride attenuates Aβ production via suppressing BACE1 activity in cortical neurons
  Feiyang Liu, Yijin Wang, Ming Yan, Luyong Zhang, Tao Pang, Hong Liao
  Neuroscience Letters.2013; 557: 90.     CrossRef
• Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis
  A. Cignarelli, F. Giorgino, R. Vettor
  Archives of Physiology and Biochemistry.2013; 119(4): 139.     CrossRef
• Labisia pumilaUpregulates Peroxisome Proliferator-Activated Receptor Gamma Expression in Rat Adipose Tissues and 3T3-L1 Adipocytes
  Fazliana Mansor, Harvest F. Gu, Claes-Göran Östenson, Louise Mannerås-Holm, Elisabet Stener-Victorin, Wan Nazaimoon Wan Mohamud
  Advances in Pharmacological Sciences.2013; 2013: 1.     CrossRef
• Protocol for effective differentiation of 3T3-L1 cells to adipocytes
  Katja Zebisch, Valerie Voigt, Martin Wabitsch, Matthias Brandsch
  Analytical Biochemistry.2012; 425(1): 88.     CrossRef

With a developing worldwide epidemic of diabetes mellitus, the renal complications associated with diabetes have become a serious health concern. Primary therapy for treating diabetic nephropathy is a multifactorial process. Peroxisome proliferator-activated receptor alpha (PPARα) agonists have been used primarily in clinical practice for the treatment of dyslipidemia and insulin resistance. Given that PPARα expression and regulation of metabolic pathways are involved in oxidative stress, inflammation, blood pressure regulation, and the renin-angiotensin aldosterone system, PPARα likely influences the development and pathogenesis of diabetic nephropathy via indirect effects on glucose and lipid homeostasis and also by direct action on the kidneys. These findings suggest that PPARα may become an important therapeutic target for treating diabetic renal complications.

Citations

Citations to this article as recorded by  

• Coriander microgreens and baby greens: Comparison of volatile and non-volatile metabolites and potential therapeutic effects on type 2 diabetes mellitus and obesity
  Yuan Zhong, Yuxuan Xie, Jian Lyu, Yandong Xie, Cai Zhao, Jihua Yu
  Food Research International.2025; 202: 115759.     CrossRef
• Oxidative stress, inflammation, and steatosis elucidate the complex dynamics of HgCl2 induced liver damage in Channa punctata
  Shefalee Singh, Shikha Dwivedi, Adeel Ahmad Khan, Anamika Jain, Shraddha Dwivedi, Kamlesh Kumar Yadav, Indrani Dubey, Abha Trivedi, Sunil P. Trivedi, Manoj Kumar
  Scientific Reports.2024;[Epub]     CrossRef
• Ethyl Acetate Fractions of Salvia miltiorrhiza Bunge (Danshen) Crude Extract Modulate Fibrotic Signals to Ameliorate Diabetic Kidney Injury
  Yung-Chien Hsu, Ya-Hsueh Shih, Cheng Ho, Cheng-Chi Liu, Chia-Ching Liaw, Hui-Yi Lin, Chun-Liang Lin
  International Journal of Molecular Sciences.2024; 25(16): 8986.     CrossRef
• Peroxisome Proliferator-Activated Receptor Alpha Stimulation Preserves Renal Tight Junction Components in a Rat Model of Early-Stage Diabetic Nephropathy
  Lorena Rosas-Martínez, Rafael Rodríguez-Muñoz, María del Carmen Namorado-Tonix, Fanis Missirlis, Leonardo del Valle-Mondragón, Alicia Sánchez-Mendoza, José L. Reyes-Sánchez, Luz Graciela Cervantes-Pérez
  International Journal of Molecular Sciences.2024; 25(23): 13152.     CrossRef
• The Proteome of Circulating Large Extracellular Vesicles in Diabetes and Hypertension
  Akram Abolbaghaei, Maddison Turner, Jean-François Thibodeau, Chet E. Holterman, Christopher R. J. Kennedy, Dylan Burger
  International Journal of Molecular Sciences.2023; 24(5): 4930.     CrossRef
• Metformin mitigates renal dysfunction in obese insulin-resistant rats via activation of the AMPK/PPARα pathway
  Laongdao Thongnak, Nattavadee Pengrattanachot, Sasivimon Promsan, Nichakorn Phengpol, Prempree Sutthasupha, Krit Jaikumkao, Anusorn Lungkaphin
  Archives of Pharmacal Research.2023; 46(5): 408.     CrossRef
• A comprehensive insight into the molecular and cellular mechanisms of the effects of Propolis on preserving renal function: a systematic review
  Paniz Anvarifard, Maryam Anbari, Alireza Ostadrahimi, Mohammadreza Ardalan, Zohreh Ghoreishi
  Nutrition & Metabolism.2022;[Epub]     CrossRef
• APX-115, a pan-NADPH oxidase inhibitor, protects development of diabetic nephropathy in podocyte specific NOX5 transgenic mice
  Eun Soo Lee, Hong Min Kim, Sun Hee Lee, Kyung Bong Ha, Yoon Soo Bae, Soo Jin Lee, Sung Hwan Moon, Eun Young Lee, Ji-Hye Lee, Choon Hee Chung
  Free Radical Biology and Medicine.2020; 161: 92.     CrossRef
• Fenofibrate decreased microalbuminuria in the type 2 diabetes patients with hypertriglyceridemia
  Xiaomeng Sun, Jia Liu, Guang Wang
  Lipids in Health and Disease.2020;[Epub]     CrossRef
• AMPK allostery: A therapeutic target for the management/treatment of diabetic nephropathy
  Kehinde Sulaimon Ayinde, Olamide Tosin Olaoba, Boyenle Ibrahim, Du Lei, Qian Lu, Xiaoxing Yin, Temitope Isaac Adelusi
  Life Sciences.2020; 261: 118455.     CrossRef
• Greater efficacy of atorvastatin versus a non-statin lipid-lowering agent against renal injury: potential role as a histone deacetylase inhibitor
  Ravi Shankar Singh, Dharmendra Kumar Chaudhary, Aradhana Mohan, Praveen Kumar, Chandra Prakash Chaturvedi, Carolyn M. Ecelbarger, Madan M. Godbole, Swasti Tiwari
  Scientific Reports.2016;[Epub]     CrossRef
• Upregulation of SIRT1-AMPK by thymoquinone in hepatic stellate cells ameliorates liver injury
  Yong Yang, Ting Bai, You-Li Yao, De-Quan Zhang, Yan-Ling Wu, Li-Hua Lian, Ji-Xing Nan
  Toxicology Letters.2016; 262: 80.     CrossRef
• Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan
  Makoto Harada, Yuji Kamijo, Takero Nakajima, Koji Hashimoto, Yosuke Yamada, Hisashi Shimojo, Frank J. Gonzalez, Toshifumi Aoyama
  Clinical Science.2016; 130(21): 1969.     CrossRef
• Anthocyanin-rich Seoritae extract ameliorates renal lipotoxicity via activation of AMP-activated protein kinase in diabetic mice
  Eun Sil Koh, Ji Hee Lim, Min Young Kim, Sungjin Chung, Seok Joon Shin, Bum Soon Choi, Hye Won Kim, Seong Yeon Hwang, Sae Woong Kim, Cheol Whee Park, Yoon Sik Chang
  Journal of Translational Medicine.2015;[Epub]     CrossRef
• Diabetic Kidney Disease: From Epidemiology to Clinical Perspectives
  Cheol Whee Park
  Diabetes & Metabolism Journal.2014; 38(4): 252.     CrossRef
• Peroxisome proliferator-activated receptor agonists in a battle against the aging kidney
  Marijn M. Speeckaert, Céline Vanfraechem, Reinhart Speeckaert, Joris R. Delanghe
  Ageing Research Reviews.2014; 14: 1.     CrossRef
• Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats
  Pitchai Balakumar, Rajavel Varatharajan, Ying Hui Nyo, Raja Renushia, Devarajan Raaginey, Ann Nah Oh, Shaikh Sohrab Akhtar, Mani Rupeshkumar, Karupiah Sundram, Sokkalingam A. Dhanaraj
  Pharmacological Research.2014; 90: 36.     CrossRef
• Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy
  Supriya Kadian, Nanjaian Mahadevan, Pitchai Balakumar
  European Journal of Pharmacology.2013; 698(1-3): 388.     CrossRef
• Age-Associated Molecular Changes in the Kidney in Aged Mice
  Ji Hee Lim, Eun Nim Kim, Min Young Kim, Sungjin Chung, Seok Joon Shin, Hyung Wook Kim, Chul Woo Yang, Yong-Soo Kim, Yoon Sik Chang, Cheol Whee Park, Bum Soon Choi
  Oxidative Medicine and Cellular Longevity.2012; 2012: 1.     CrossRef
• Epidemiology of Obesity, the Metabolic Syndrome, and Chronic Kidney Disease
  Rikki M. Tanner, Todd M. Brown, Paul Muntner
  Current Hypertension Reports.2012; 14(2): 152.     CrossRef

Citations

Citations to this article as recorded by  

• CTX-1 and TRACP-5b as biomarkers for osteoporosis risk in type 2 diabetes mellitus: a cross-sectional study
  Madhura Roy, Haya Majid, Parvej Khan, Nikhil Sharma, Sunil Kohli, Sajad Ul Islam, Divya Vohora, Nidhi
  Journal of Diabetes & Metabolic Disorders.2024; 23(2): 2055.     CrossRef
• Relationship between hs-CRP and HbA1c in Diabetes Mellitus Patients: 2015–2017 Korean National Health and Nutrition Examination Survey
  Yo-Han Seo, Hee-Young Shin
  Chonnam Medical Journal.2021; 57(1): 62.     CrossRef
• Correlation between Serum Osteocalcin and Hemoglobin A1c in Gwangju General Hospital Patients
  Yo-Han Seo, Hee-Young Shin
  The Korean Journal of Clinical Laboratory Science.2018; 50(3): 313.     CrossRef
• Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice
  Xue-Ju Li, Zhe Zhu, Si-Lin Han, Zi-Long Zhang
  International Journal of Molecular Medicine.2016; 38(6): 1661.     CrossRef
• The association of Osteoporosis and Thyroid Hormone in euthyroid adults
  Hyun Yoon, Eun-Jin Ryu
  Journal of the Korea Academia-Industrial cooperation Society.2015; 16(2): 1137.     CrossRef
• A Study on the Correlation between Menopausal Rating Scale and Bone Mineral Density for Menopausal Osteoporosis Patients※
  Kyu In Kwak, Jae Hui Kang, Yun Joo Kim, Hyun Lee
  The Acupuncture.2014; 31(3): 25.     CrossRef
• Factors Associated with Bone Mineral Density in Korean Postmenopausal Women Aged 50 Years and Above: Using 2008-2010 Korean National Health and Nutrition Examination Survey
  Son-Ok Mun, Jihye Kim, Yoon Jung Yang
  Korean Journal of Community Nutrition.2013; 18(2): 177.     CrossRef
• Influencing Factors of Bone Mineral Density in Men
  Dong-Ha Lee, Eun-Nam Lee
  Journal of muscle and joint health.2011; 18(1): 5.     CrossRef

Citations

Citations to this article as recorded by  

• The Differences of Metabolic Syndrome Risk Factors according to Obesity and Abdominal Obesity in Elderly Korean Women
  Kyung-A Shin
  The Korean Journal of Clinical Laboratory Science.2016; 48(4): 304.     CrossRef
• Effects of Soybean and DJI Chungkukjang Powder on Blood Glucose and Serum Lipid Reduction in db/db Mice
  Jae-Joon Lee, Ah-Ra Kim, Hae-Choon Chang, Hae-Ok Jung, Myung-Yul Lee
  Journal of the Korean Society of Food Science and Nutrition.2012; 41(8): 1086.     CrossRef
• Comparative analysis of fat and muscle proteins in fenofibratefed type II diabetic OLETF rats: the fenofibrate-dependent expression of PEBP or C11orf59 protein
  Jong-Ryeal Hahm, Jin-Sook Ahn, Hae-Sook Noh, Seon-Mi Baek, Ji-Hye Ha, Tae-Sik Jung, Yong-Jun An, Duk-Kyu Kim, Deok-Ryong Kim
  BMB Reports .2010; 43(5): 337.     CrossRef
• Comparative analysis of fat and muscle proteins in fenofibratefed type II diabetic OLETF rats: the fenofibrate-dependent expression of PEBP or C11orf59 protein
  Jong-Ryeal Hahm, Jin-Sook Ahn, Hae-Sook Noh, Seon-Mi Baek, Ji-Hye Ha, Tae-Sik Jung, Yong-Jun An, Duk-Kyu Kim, Deok-Ryong Kim
  BMB Reports.2010; 43(5): 337.     CrossRef

Citations

Citations to this article as recorded by  

• Enhancing Mitochondrial Maturation in iPSC-DerivedCardiomyocytes: Strategies for Metabolic Optimization
  Dhienda C. Shahannaz, Tadahisa Sugiura, Brandon E. Ferrell
  BioChem.2025; 5(3): 23.     CrossRef
• Beneficial effect of Combination with Korean Red Ginseng and Morus alba in metabolic syndrome
  Yun Jung Lee, Hye Yoom Kim, Jung Joo Yoon, So Min Lee, You Mee Ahn, Joung Hyun Kho, Min Chul Kho, Ho Sub Lee, Kyung Min Choi, Dae Gill Kang
  The Korea Journal of Herbology.2012; 27(6): 99.     CrossRef
• Effects of Mixed Extract from Lycium chinense, Cordyceps militaris, and Acanthopanax senticosus on Glucose-Regulating Enzymes of HepG2 in Hyperglycemic Conditions
  Dae-Jung Kim, Jeong-Mi Kim, Tae-Hyuk Kim, Jong-Mi Baek, Hyun-Sook Kim, Myeon Choe
  Journal of the Korean Society of Food Science and Nutrition.2010; 39(9): 1257.     CrossRef

Citations

Citations to this article as recorded by  

• Eating behaviors, home meal replacement consumption, and nutrition quotient: a comparative study of male shift and non-shift workers in Chungcheong, Korea
  Yeon Jin Lee, Munkyong Pae
  Nutrition Research and Practice.2025; 19(5): 758.     CrossRef